avapro and Vasculitis
avapro has been researched along with Vasculitis in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" Further research is necessary to determine which AT1RBs and which dosing regimens are optimal." | 2.41 | Emerging role of angiotensin II type 1 receptor blockers for the treatment of endothelial dysfunction and vascular inflammation. ( Mancini, GB, 2002) |
"Atherosclerosis is a chronic inflammatory disease in which the renin-angiotensin-aldosterone system plays an important role." | 1.36 | Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice. ( Chen, Y; Cheng, X; Ding, YJ; Liao, MY; Liao, YH; Tang, TT; Xie, JJ; Yao, R; Yu, X, 2010) |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Yao, R | 1 |
Cheng, X | 1 |
Chen, Y | 1 |
Xie, JJ | 1 |
Yu, X | 1 |
Liao, MY | 1 |
Ding, YJ | 1 |
Tang, TT | 1 |
Liao, YH | 1 |
Mancini, GB | 1 |
Reviews
1 review available for avapro and Vasculitis
Article | Year |
---|---|
Emerging role of angiotensin II type 1 receptor blockers for the treatment of endothelial dysfunction and vascular inflammation.
Topics: Acrylates; Aged; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Coronary A | 2002 |
Other Studies
1 other study available for avapro and Vasculitis
Article | Year |
---|---|
Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Bipheny | 2010 |